Crossmark

Burosumab in X-linked hypophosphatemia: a profile of its use in the USA

Crossref DOI link: https://doi.org/10.1007/s40267-018-0560-9

Published Online: 2018-10-08

Published Print: 2018-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lyseng-Williamson, Katherine A.
License Information

Text and Data Mining valid from 2018-10-08
More Information

Article History

First Online: 8 October 2018

Change Date: 12 November 2018

Change Type: Correction

Change Details: The article Burosumab in X-linked hypophosphatemia

Compliance with ethical standards

:

: The preparation of this review was not supported by any external funding.

: K.A. Lyseng-Williamson is an employee of Adis/Springer, is responsible for the article content and declares no conflicts of interest.